Cellular Aspects of Shigella Pathogenesis: Focus on the Manipulation of Host Cell Processes by Samuel A. Killackey et al.
REVIEW
published: 31 March 2016
doi: 10.3389/fcimb.2016.00038
Frontiers in Cellular and Infection Microbiology | www.frontiersin.org 1 March 2016 | Volume 6 | Article 38
Edited by:
William D. Picking,
University of Kansas, USA
Reviewed by:
Cammie Lesser,
Harvard Medical School, USA
Alfredo G. Torres,
University of Texas Medical Branch,
USA
*Correspondence:
Stephen E. Girardin
stephen.girardin@utoronto.ca
Received: 26 January 2016
Accepted: 17 March 2016
Published: 31 March 2016
Citation:
Killackey SA, Sorbara MT and
Girardin SE (2016) Cellular Aspects of
Shigella Pathogenesis: Focus on the
Manipulation of Host Cell Processes.
Front. Cell. Infect. Microbiol. 6:38.
doi: 10.3389/fcimb.2016.00038
Cellular Aspects of Shigella
Pathogenesis: Focus on the
Manipulation of Host Cell Processes
Samuel A. Killackey 1, Matthew T. Sorbara 2 and Stephen E. Girardin 1, 2*
1Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada, 2Department of
Immunology, University of Toronto, Toronto, ON, Canada
Shigella is a Gram-negative bacterium that is responsible for shigellosis. Over the years,
the study of Shigella has provided a greater understanding of how the host responds
to bacterial infection, and how bacteria have evolved to effectively counter the host
defenses. In this review, we provide an update on some of the most recent advances
in our understanding of pivotal processes associated with Shigella infection, including
the invasion into host cells, the metabolic changes that occur within the bacterium and
the infected cell, cell-to-cell spread mechanisms, autophagy and membrane trafficking,
inflammatory signaling and cell death. This recent progress sheds a new light into the
mechanisms underlying Shigella pathogenesis, and also more generally provides deeper
understanding of the complex interplay between host cells and bacterial pathogens in
general.
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INTRODUCTION
Bacteria of the genus Shigella are human pathogens that infect the gastro-intestinal tract and cause
acute shigellosis. Shigellae are Gram-negative, non-motile, facultative anaerobic pathogens that
are closely related to Escherichia coli but have evolved specific traits of pathogenicity, physiology
and serology (Ud-Din and Wahid, 2014). Shigella infection can occur by the fecal-oral route of
transmission, person-to-person contact or ingestion of contaminated food or water. There are four
serogroups of Shigella: Shigella flexneri, S. dysenteriae, S. boydii, and S. sonnei, all of which are able
to cause disease in humans (Livio et al., 2014). Diarrhea is an early symptom of shigellosis and
may be initiated as the bacteria reach the small intestine. However, the bacteria predominantly
target the colonic epithelium that they rapidly invade, causing inflammatory colitis (Ashida et al.,
2015). According to data from the Centers for Disease Control (CDC) and Prevention, Shigella
is estimated to cause 80–165 million cases worldwide every year, resulting in 0.6 million deaths,
particularly in young children. Shigella spp. are endemic in a number of tropical and sub-tropical
regions of the world where S. flexneri is the most common cause of disease, while S. sonnei is more
frequently associated with infection in industrialized countries (Liang et al., 2007). Infection with
S. boydii and S. dysenteriae are less common overall but can be locally endemic, such as in South
Asia and in Sub-Saharian Africa (Kotloff et al., 2013).
Shigella is a strict human pathogen, and therefore animal models of infection have been
difficult to establish, and only recapitulate some aspects of pathogenicity. Nonetheless, several
animal models have been developed that include the rabbit ligated ileal loop model, the newborn
mouse enteric infection model and the guinea pig enteric infection model (Perdomo et al., 1994;
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Fernandez et al., 2003; Shim et al., 2007). Recently, a new model
of infection in the Zebrafish larvae was developed, which allowed
study of the interaction between Shigella and phagocytes in vivo
(Mostowy et al., 2013).
While studying the mechanisms of Shigella pathogenesis in
vivo has proven difficult, Shigella infection, in particular using
the S. flexneri species, has become one of the most widely used
paradigms of host-bacterial interaction in cellular models of
infection. Together with Mycobacteria, Salmonella and Listeria,
Shigella represents one of the most studied bacteria that can
invade (i.e., cross the host plasma membrane) host cells. Among
those bacteria, the invasion mechanism triggered by Shigella
has similarities to the one induced by the other Gram-negative
bacterium, Salmonella; however, in contrast to Salmonella and
Mycobacteria, Shigella rapidly escapes the entry vacuole, moves
freely in the host cytosol, and is able to spread from cell to cell,
which are properties shared with the Gram-positive bacterium
Listeria. Thus, host cell invasion by Shigella has overall unique
characteristics, and the use of this bacterium as a model of host-
bacteria interaction over the past four decades has considerably
increased our understanding of bacterial pathogenesis. In this
review, we will provide an overview of some of the most recent
progress that was made in cellular microbiology and innate
immunity, using Shigella as a model.
SHIGELLA INVASION
Strikingly, the inoculum size necessary for Shigella infection is as
low as 100 bacteria (DuPont et al., 1989). In order to establish a
productive infection, Shigella transits across the colonic epithelial
layer throughM cells, and is then able to efficiently invade colonic
epithelial cells from the basolateral face (Phalipon and Sansonetti,
2007). Invasion of the colonic epithelium and spread from cell-
to-cell is the primary driver of the severe inflammatory response
associated with infection.
Shigella triggers its own uptake into epithelial cells using a
type III secretion system (T3SS) (Figure 1). The proteins of
the T3SS are encoded by a large 220 kb virulence plasmid
and form a macromolecular needle-like structure that allows
for the delivery of effector proteins across the membrane of
the target eukaryotic cell. Prior to delivery of effectors, Shigella
first adheres to the host cell, despite the absence of classical
adhesion proteins. Recent work has demonstrated that the
Shigella surface protein, IcsA, functions as an adhesin that is
activated by bile-salts, and facilitates interaction with host cells
after initial activation of the T3SS (Brotcke Zumsteg et al.,
2014). Bile-salts also promote the secretion of OspE1 and OspE2
which remain on the bacterial outer-membrane and increase
adherence to polarized cells (Faherty et al., 2012). In addition,
bile-salts, in particular deoxycholate, promote final assembly of
the T3SS in an activation-ready state (Stensrud et al., 2008).
Furthermore, bacterial binding to filopodia through the T3SS
components, IpaB and IpaD, also promotes interaction and
invasion (Romero et al., 2011). Interestingly, Marteyn et al.
demonstrated that Shigella blocks secretion through the T3SS
in anaerobic conditions through fumarate and nitrate reductase
(FNR)-mediated suppression of spa32 and spa33 transcription
(Marteyn et al., 2010). Detection of O2 in the region immediately
adjacent to the epithelial barrier relieves this transcriptional
suppression, triggering spa32 and spa33 expression leading to
activation of the T3SS and efficient invasion (Marteyn et al.,
2010). Altogether, these findings indicate that Shigella has evolved
to acutely sense when it is in the appropriate gut environment to
trigger increased adherence and T3SS activity.
At the distal end of the T3SS is the tip complex composed of
IpaB, IpaC, and IpaD (Veenendaal et al., 2007). IpaD facilitates
assembly of IpaB and IpaC onto the needle, and IpaB and
IpaC are hydrophobic proteins that are able to insert into
eukaryotic membranes to form a pore that allows for effector
delivery (Blocker et al., 1999; Veenendaal et al., 2007). Membrane
insertion and T3SS activity is promoted by interaction of IpaB
with cholesterol in the host membrane (Hayward et al., 2005;
Epler et al., 2009). Prior to insertion, IpaB functions to block
secretion through the T3SS, acting as a molecular plug that is
removed with insertion into the host membrane (Roehrich et al.,
2010).
T3SS-dependent delivery of effector proteins generates a
region of actin remodeling and polymerization that ultimately
leads to membrane ruﬄing and the uptake of the associated
Shigella. The effectors IpgB1 and IpgB2 act as guanine nucleotide
exchange factors (GEFs) for Rac and RhoA to drive actin
remodeling (Huang et al., 2009). Indeed, a Shigella double mutant
for IpgB1 and IpgB2 is unable to efficiently invade intestinal
epithelial cells (Hachani et al., 2008). In addition, Shigella IpgD is
a phosphatase that generates phosphotidyl-inositol-5-phosphate
to promote actin polymerization (Pendaries et al., 2006). The
tip complex protein, IpaC, promotes invasion by activating Src
kinase and Cdc42 (Mounier et al., 2009). Collectively, these
events generate a region of intense actin remodeling. Finally,
during the effector-induced membrane ruﬄes, IpaA binds to
host-cell vinculin, a component of focal adhesions. Interaction
with vinculin functions to anchor Shigella to the site ofmembrane
ruﬄing (Izard et al., 2006).
Once Shigella is internalized, it rapidly escapes from the entry
vacuole. IpaB and IpaC insertion into the vacuole membrane
is thought to form holes promoting vacuole breakdown. More
recent work identified that the recruitment of the host cell
recycling endosome machinery by IpgD was critical for the rapid
escape from the entry vacuole (Mellouk et al., 2014). Mellouk
et al. demonstrated that IpgD phosphatase activity is required
to drive recruitment of Rab11-positive recycling endosomes to
the entry vacuole; however, the exact mechanism through which
recycling endosomes promote vacuole escape requires further
examination (Mellouk et al., 2014).
IMPACT OF SHIGELLA INVASION ON
METABOLIC PATHWAYS OF THE HOST
AND THE PATHOGEN
The invasion of host cells by Shigella requires a dramatic
adaptation of the pathogen to a new environment, in which
access to a number of nutrients or metabolic cofactors, such
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FIGURE 1 | Distinct phases of invasion and autophagy targeting during Shigella infection. Shigella adheres to the basolateral surface of epithelial cells, forms
a pore in the eukaryotic membrane, and delivers effector proteins to induce its uptake (Box 1). The first wave of autophagy targeting follows initial invasion and is
mediated by recruitment of the autophagy machinery to the site of entry. The intracellular PRRs, NOD1 and NOD2, play a critical role through the recruitment of
ATG16L1. Following escape from the entry vacuole, Shigella drive actin polymerization at one pole through IcsA-dependent recruitment of N-WASP and ARP2/3. This
allows for intracellular motility. This process is countered by the host’s attempt to trap bacteria in septin-derived cages that enables autophagy targeting. Once motile
and free in the cytosol the host is unable to target Shigella to autophagy. Actin-based motility allows Shigella to spread from cell-cell, and it efficiently escapes into the
second cell using a reactivated T3SS. This secondary invasion event allows for additional autophagy targeting. IcsB mutants that are less efficient at escape are more
readily targeted by autophagy at this step.
as carbon sources, iron and oxygen is limited and is under
the control of the host (Figure 2). Iron restriction is among
the most well studied examples of nutrient stress that Shigella
encounters as it grows inside host cells. While the host
has developed multiple strategies, including the expression
of iron-binding proteins, to limit the concentration of free
iron inside cells because of its inherent toxicity, Shigella
expresses molecules such as siderophores, heme transporters
as well as ferric and ferrous iron transport systems that can
capture intracellular iron (Payne et al., 2006). Recently, global
proteomic analysis of Shigella inside host cells emphasized the
importance of iron starvation stress in the intracellular milieu
(Pieper et al., 2013). In particular, iron acquisition systems
(Iut, Sit, FhuA, and Feo) and the iron starvation, stress-
associated Suf protein are strongly upregulated in intracellular
Shigella. In agreement, a global transcriptional study of Shigella
growing inside host cells revealed that the bacteria experienced
restricted levels of iron, magnesium and phosphate (Lucchini
et al., 2005). Once properly scavenged, Shigella use iron for a
number of essential processes ranging from DNA replication
to respiration (Wei and Murphy, 2016). Moreover, progress
has been made with regards to the intracellular source of
carbon required by Shigella for its biosynthetic pathways.
The global proteome analysis mentioned above also identified
that mixed-acid fermentation, and metabolism of pyruvate
in particular, is required for optimal intracellular growth of
S. flexneri (Pieper et al., 2013). In contrast to fermentation
pathway enzymes, components of the tricarboxylic acid (TCA)
cycle were decreased in the intracellular bacteria, consistent
with the notion that fermentation, rather than respiration,
predominates in the intracellular environment. Shigella uses
three glycolytic pathways to produce pyruvate from glucose:
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FIGURE 2 | Shigella infection induces metabolic changes in the host and the bacteria. Amino acid (AA) starvation is induced following bacterial infection, and
this leads to numerous changes in the metabolism of the host cell including the induction of the integrated stress response (ISR) causing transcriptional
reprogramming and formation of stress granules. The inhibition of mTOR signaling is also seen, with multiple downstream effects. Within Shigella, key cofactors such
as iron need to be scavenged for essential survival processes. The tricarboxylic acid (TCA) cycle is less important than other processes such as fermentation. The
Embden-Meyerhof-Parnas (EMP) pathway predominates the generation of pyruvate in comparison to the pentose-phosphate pathway (PPP) and the
Entner-Doudoroff (ED) pathway.
the Embden-Meyerhof-Parnas (EMP) pathway, the pentose-
phosphate pathway (PPP) and the Entner-Doudoroff (ED)
pathway. Studies by Payne’s group demonstrated the importance
of the EMP pathway, which converts glucose to pyruvate through
the glucose-6-phosphate/fructose-6-phosphate/glyceraldehyde-
3-phosphate intermediates, while the PPP and ED pathways
were dispensable for Shigella intracellular growth (Waligora
et al., 2014). Importantly, growth defects caused by glycolysis
mutants could be overcome by supplementation with pyruvate,
showing that this molecule is an essential carbon source for
Shigella intracellular growth. In a complementary study, Kentner
et al. analyzed host fermentation pathways in uninfected vs.
Shigella-infected cells (Kentner et al., 2014). They observed
that host glycolytic pathways were not substantially affected
by the pathogen, but infected cells excreted acetate instead
of pyruvate and lactate, suggesting that the latter molecules
had been captured and used by Shigella for its metabolism.
Importantly, this study also showed that pyruvate was the most
important metabolite required for Shigella intracellular growth,
while it appeared that access to host amino acids or fatty acids
was not limiting for intracellular bacterial growth. This finding
may reflect the landscape through which Shigella evolved over
time, where amino acids and fatty acids were more limited, and
access was more difficult than for attaining other metabolites.
While intracellular Shigella experience metabolic and nutrient
stress, the infection also has major consequences for the
infected host cell in terms of metabolic stress pathway
induction. The mechanistic target of rapamycin (mTOR) and
integrated stress response (ISR) pathways represent two major
signaling axes in eukaryotic cells that control metabolic stress
responses to nutrient limitation. We recently demonstrated
that infection by Shigella resulted in potent inhibition of
mTOR signaling, as well as induction of the ISR, and that the
underlying mechanism was the induction of an amino acid (AA)
starvation response in infected host cells (Tattoli et al., 2012).
This AA starvation response upregulated the general control
nonderepressible (GCN2)/eukaryotic translation initiation factor
2 (eIF2α)/activating transcription factor 3 (ATF3) axis of the
ISR, resulting in stress-associated transcriptional reprogramming
and accumulation of messenger ribonucleic acid (mRNA) stress
granules in infected cells. Inhibition of the mTOR signaling
axis caused dephosphorylation of 4E-binding protein 1 (4E-
BP1) and S6 kinase 1 (S6K1), general inhibition of translation
and upregulation of autophagy (Tattoli et al., 2012). It is likely
that the down-regulation of mTOR signaling in infected host
cells is an important step in innate immune defense against
Shigella, since autophagy against intracellular pathogens (also
known as xenophagy) is critical for host defense. Interestingly,
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Lu et al. recently demonstrated that Shigella used the effector
protein OspB to inhibit this process in the first phase of the
infection by turning onmTOR complex 1 through the scaffolding
protein IQ motif-containing guanosine triphosphate (GTP)ase-
activating protein 1 (IQGAP1; Lu et al., 2015).
An unexpected consequence of the induction of metabolic
stress pathways following Shigella infection was reported.
Specifically, we observed in Shigella-infected cells the
modulation of U small nuclear ribonucleic acid (snRNA)
cytosolic maturation, which is a critical step in the control
of the assembly of the spliceosome, the molecular machinery
responsible for mRNA splicing (Tsalikis et al., 2015). We
demonstrated that this effect required bacterial invasion and
could be recapitulated by AA starvation, endoplasmic reticulum
stress or mTOR inhibition (Tsalikis et al., 2015). While it
is likely that the adaptation of the spliceosome metabolism
during infection mirrors translation inhibition and is an
energy conservation mechanism, the results obtained in this
study suggest that this process plays a role in the overall
regulation of stress- and inflammation-associated responses
observed during infection. It remains to be determined if
the regulation of the U snRNA levels in infected cells also
contributes to shaping alternative splicing programs in infected
cells, and if this potential mechanism is important for host
defense.
HOST DETECTION OF SHIGELLA
The host detects invasive pathogens through both intracellular
and extracellular sensing mechanisms. Among others, the Toll-
like receptors (TLRs) sense the extracellular and endosomal
environment and drive proinflammatory signaling in response
to specific stimulation. This TLR-based detection plays a major
role in the response to Shigella by myeloid cells (Girardin
et al., 2001). For example, it is well documented that detection
of extracellular lipopolysaccharide (LPS) by TLR4 leads to an
inflammatory response in myeloid cells (Poltorak et al., 1998;
Hoshino et al., 1999). However, the intracellular detection
of Shigella in epithelial cells has proven to be critical for
the host response. The Nod-like receptors NOD1 and NOD2
respond to Shigella peptidoglycan (PGN) and control both
mitogen-activated protein kinase (MAPK) and nuclear factor
κB (NF-κB) proinflammatory signaling (Girardin et al., 2001,
2003a,b,c; Chamaillard et al., 2003; Inohara et al., 2003). Studies
have shown that NOD1 is essential for the induction of
chemokines and cytokines in response to either intracellular
Shigella or PGN. Bacterial replication inside the host cells
releases PGN, which triggers the NOD1-receptor-interacting
protein 2 (RIP2)-inhibitor of nuclear factor kappa-B kinase
(IKK) pathway leading to the production of interleukin 8
(IL-8; Girardin et al., 2001). NOD1 remains the primary
intracellular detector of Shigella infection, and is upstream
of inflammatory as well as survival pathways that help the
host handle infection by the pathogen. One such survival
pathway involving NOD1-RIP2-IKKβ-NF-κB in epithelial cells
counters the mitochondrial damage and stress pathway triggered
by Shigella (Carneiro et al., 2009). The signaling pathways
downstream of these receptors can function in isolation or in
combination, leading to anti-microbial responses. For example,
TLR stimulation can aid in NLR driven processes, as seen
with the TLR-driven expression of the precursors of IL-18 and
IL-1β, which are processed intracellularly as a consequence
of NLR-dependent activation of inflammasomes (Miao et al.,
2010). This allows for additional levels of amplification,
ensuring a rapid response is initiated once a potential threat
is verified through multiple sensors, both intracellularly and
extracellularly.
After macrophages internalize Shigella, a proinflammatory,
caspase-dependent form of cell death known as pyroptosis is
induced by bacterial components as well as downstream danger
signals coming from dead or dying host cells. The rod protein
MxiI and the needle protein MxiH of Shigella T3SS have been
shown to stimulate the NLR family CARD domain containing
4 protein (NLRC4) inflammasome after being sensed by NLR
family, apoptosis inhibitory protein 2 (NAIP2) and human NAIP
(murine NAIP1) respectively (Yang et al., 2013; Suzuki et al.,
2014). The canonical NLR family, pyrin domain containing 3
(NLRP3) inflammasome is known to respond to phagocytic
membrane remnants, among other stimuli (Ashida et al., 2014).
Taken together, the presence of an intracellular system that
generates specificity through different upstream sensors allows
a few key effectors to carry out the same function while
detecting a wide diversity of stimuli. However, the discovery of
a host method for sensing intracellular LPS has uncovered the
existence of a noncanonical inflammasome. This noncanonical
inflammasome pathway requires caspase-11 (mouse homolog
of human caspase-4) as an upstream sensor of intracellular
LPS (Kayagaki et al., 2013). Caspase-11 induces pyroptosis
independently of NLRP3 or caspase-1, but requires the latter
components to induce the IL-1β and IL-18 cytokine response
(Kayagaki et al., 2011). The discovery of this caspase-11 function
changed the belief that LPS was only sensed extracellularly, by
TLR4. A redundant system for sensing LPS reinforces the reliance
on both intracellular and extracellular sensors for bacterial
components, which together may serve to induce multiple waves
of host defense. Although these findings concerning caspase-
11 are not Shigella-specific, they suggest a mechanism that may
be at play in cells in response to Shigella as well as other
pathogens.
As the pathways for sensing intracellular viral nucleic
acids have become more comprehensive, investigation into the
intracellular sensors of bacterial nucleic acid has become an
area of interest. Studies have reported that the intracellular
detector of double-stranded deoxyribonucleic acid (dsDNA) is
cyclic GMP-AMP synthase (cGAS), an enzyme that generates
cyclic guanosine monophosphate-adenosine monophosphate
(cGAMP) which then serves as a downstream second messenger
to activate stimulator of interferon genes (STING) leading to
the generation of type-1 interferons and NF-κB signaling (Broz
and Monack, 2013; Wu et al., 2013). Cytosolic dsDNA associated
with Shigella infection could arise from host cell damage or the
presence of intracellular bacteria, both being situations where the
host would benefit from proinflammatory signaling. While host
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cells independently possess multiple ways to respond to Shigella
infection, recent studies highlight the intercellular transport
of cGAMP via gap junctions. This transferred cGAMP was
shown to stimulate STING in non-infected cells adjacent to the
infected cell, allowing proactive defense preparation including
proinflammatory cytokine expression in non-infected host cells
(Kasper et al., 2010; Ablasser et al., 2013). Considering the
bacterium rapidly moves from one cell to an adjacent cell
using cell-to-cell spread mechanisms, any form of preparation
that surrounding cells can take to preemptively raise a
defense would be beneficial to combat Shigella infection (see
below).
SHIGELLA EFFECTORS AND
MANIPULATION OF HOST PROCESSES
Shigella has evolved sophisticated strategies to escape the entry
vacuole and to replicate in the host’s intracellular compartment.
These strategies depend on protein effectors which together
greatly contribute to the manipulation of key cellular processes
by the bacterial pathogen (Table 1). The effectors delivered
by Shigella via the T3SS can be split up into a first and
second wave. The first wave of effectors, as mentioned above,
are essential for actin remodeling and subsequent invasion
into host epithelial cells, and include proteins such as IpaA,
TABLE 1 | Shigella effectors manipulate a variety of host processes.
Summary of Shigella effectors and their mechanisms of action
Shigella
effector
Host targets Effect on host process
OspE1 Bind to exterior of polarized cells Increase adherence to polarized cells
OspE2 Bind to exterior of polarized cells Increase adherence to polarized cells
IpgB1 Act as GEF for Rac Induce actin remodeling to facilitate invasion
IpgB2 Act as GEF for RhoA Induce actin remodeling to facilitate invasion
IpgD Act as phosphatase to generate PI5P Induce actin remodeling to facilitate invasion
IpaB Bind to filopodia and cholesterol on the host cell surface
Insert into vacuole membrane
Reduce and disrupt balanced levels of cholesterol and lipids
Insert into eukaryotic membrane to form a pore
Facilitate invasion
Form T3SS complex
Promote vacuole breakdown
Interfere with proper Golgi function
IpaD Bind to filopodia on the host cell surface Facilitate interaction and invasion
Form T3SS complex
IpaC Activate Src Kinase and Cdc42
Insert into vacuole membrane
Facilitate invasion
Form T3SS complex
Promote vacuole breakdown
IpaA Host-cell focal adhesion component vinculin Functions as an anchor to the site of membrane ruffling
OspB Induce mTOR signaling through IQGAP1 Inhibit autophagy
VirA Catalyze GTP hydrolysis in Rab1
Induce p53 degradation
Disrupt ER-to-Golgi trafficking and autophagy
Block apoptosis
IpgD Host cell recycling endosome machinery
Increase levels of PI5P leading to p53 degradation
Rapid escape from the entry vacuole
Induce PI3K/Akt-dependent survival pathways
IpaJ Cleave N-myristoylated glycine from ARF1 to disrupt its localization Disrupt autophagosome maturation and host membrane trafficking
IpaH9.8 Target and degrade NEMO/IKKγ Disrupt NF-κB signaling
IpaH4.5 Target and degrade p65 subunit of NF- κB Disrupt NF- κB signaling
IpaH0722 Target and degrade TRAF2 Disrupt NF- κB signaling
OspZ Prevent nuclear translocation of p65 Disrupt NF- κB signaling
OspI Deamidate UBC13 E2 enzyme needed for activation of TRAF6 Disrupt NF- κB signaling
OspG Interfere with ubiquitin proteasomal degradation of IκB-α Disrupt NF- κB signaling
OspF Inactivate MAPK signaling components like ERK and p38 by
epigenetic modifications using its phosphothreonine lyase activity
Disrupt MAPK signaling
OspC3 Interact with caspase-4-p19 subunit and inhibit its
heterodimerization and activation
Inhibit pyroptosis within epithelial cells
IcsB Block autophagy targeting by binding Atg5
Bind cholesterol
Reduce autophagy
Escape from the vacuole following cell-to-cell spread
Such processes include apoptotic signaling in addition to other death signaling, inhibition of autophagy, actin remodeling which is used in invasion as well as motility and cell-to-cell
spread, anti-inflammatory signaling leading to an altered immune response, altered membrane dynamics and the stimulation of inflammasome formation and action. These altered
processes contribute to Shigella infection, aiding in efficient propagation of the bacteria within the host.
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IpaB, IpaC and VirA (Wang et al., 2013). Once Shigella has
entered the cell, the second wave of effectors causes changes in
host membrane trafficking, autophagy, inflammatory and death
signaling, epigenetic modifications, among other processes like
intracellular motility and intercellular dissemination that are
mentioned above (Ashida et al., 2015). These changes promote
Shigella survival, replication and spread to surrounding cells,
allowing the infection to worsen.
As will be explained in detail below, host cells undergo
autophagy in response to various stresses, one of them being
infection (Baxt and Goldberg, 2014). Shigella deliver effectors
similar to those involved in the first wave that target actin
polymerization and motility to manipulate the host machinery
involved in autophagy. Likewise, Shigella inject effectors that
interfere with host membrane trafficking. IpgD is one such
effector, and as a phosphoinositide phosphatase it promotes
phosphatidylinositol 5-phosphate (PI5P) production, which
plays numerous roles in the manipulation of host trafficking
such as increasing vacuolar membrane disruption (Ashida
et al., 2015). IpgD-driven PI5P also blocks hemichannels from
forming, preventing the release of adenosine triphosphate (ATP),
limiting the neighboring cells from sensing this potential
danger signal (Puhar et al., 2013). Three other effectors,
VirA, IpaJ and IpaB also aid in this manipulation of host
membrane trafficking. GTPases form important components
of the host secretory pathway, and are targeted by VirA and
IpaJ. VirA disrupts ER-to-Golgi trafficking and autophagy by
catalyzing GTP hydrolysis in Rab1, and IpaJ cleaves the N-
myristoylated glycine from ARF1, disrupting localization and
autophagosome maturation among other processes (Ashida
et al., 2015). Lastly, IpaB interferes with proper Golgi
functioning and protein transport through reducing, and
therefore disrupting the balanced levels of cholesterol and
lipids (Ashida et al., 2015). Thus, altering membrane dynamics
appears to be a key component of the strategy of Shigella
infection.
Inflammatory signaling is one of the fundamental host
defenses to infection, making it a candidate for Shigella targetting.
Indeed, Shigella dampens the NF-κB signaling pathway using a
number of effectors, such as the IpaH ubiquitin ligase family.
IpaH9.8 targets NF-κB essential modulator (NEMO)/IKKγ,
IpaH4.5 targets p65 subunit of NF-κB, and IpaH0722 targets
TNF Receptor-Associated Factor 2 (TRAF2), together degrading
important components of the NF-κB pathway, halting pro
inflammatory signaling (Ashida et al., 2013; Wang et al., 2013;
Giogha et al., 2014). Likewise, the Osp family of effectors also
contributes to NF-κB blockage, through different mechanisms.
OspZ prevents the translocation of p65 to the nucleus, OspI
deamidates the UBC13 E2 enzyme needed for activation of
TRAF6, and OspG interferes with the ubiquitin proteasomal
degradation of IκB-α.This multifaceted attack on NF- κB
confirms its importance in Shigella clearance. Aside from NF-
κB, Shigella effectors also target other signaling pathways that
regulate inflammation. OspF uses its phosphothreonine lyase
activity to irreversibly inactivate MAPK signaling components
like extracellular signal-regulated kinase (ERK) and p38 through
epigenetic modifications (Li et al., 2007; Newton et al., 2010;
Sanada et al., 2012; Raymond et al., 2013). These methods of
disruption lead to a decrease in proinflammatory, apoptotic and
stress signaling gene expression in host cells.
As Shigella impose such a severe halt on host NF-κB signaling,
it is reasonable to expect the host cell to become pro-apoptotic.
However, Shigella do not induce cell death in epithelial cells
as easily as they do in macrophages, and as a result, it is
common to see epithelial cells with hundreds of bacteria in
them (Mantis et al., 1996). As expected, Shigella inject effectors
that target the apoptotic pathway as well. VirA and IpgD lead
to p53 degradation through calpain activation and proteasomal
degradation respectively, halting cell death. IpgD increases levels
of PI5P which promote phosphoinositide 3-kinase (PI3K)/Akt-
dependent survival pathways, and phosphorylation of mouse
double minute 2 homolog (MDM2) which degrades p53 (Ashida
et al., 2015). A survival process induced by VirA involves
the calpain-driven cleavage of BH3 interacting domain death
agonist (BID), which leads to second mitochondria-derived
activator of caspases (SMAC) release from mitochondria and
the blockage of X-linked inhibitor of apoptosis protein (XIAP)-
driven immune response and apoptosis (Andree et al., 2014;
Ashida et al., 2014). On a similar note, although Shigella
induce pyroptosis in macrophages, recent studies have identified
the Shigella effector OspC3 as an antagonist to the caspase-
4-driven pyroptosis within epithelial cells (Kobayashi et al.,
2013). This is in line with the priority of Shigella to keep host
epithelial cells alive, which they accomplish by injecting T3SS
effectors.
CELL-TO-CELL SPREAD AND
AUTOPHAGY TARGETING
In the cytosol, Shigella use the host cell actin machinery for
intracellular motility. IcsA (VirG) interacts with and activates
neuronal Wiskott-Aldrich Syndrome protein (N-WASP), which
recruits Arp2/3 to drive actin polymerization (Egile et al., 1999).
The tyrosine kinase, Btk, phosphorylates N-WASP, increasing
Shigella motility (Egile et al., 1999; Dragoi et al., 2013).
Importantly, actin-based motility enables Shigella to spread
from cell-to-cell through the formation of protrusions in the
cell membrane that preferentially occur at tricellular junctions
(Fukumatsu et al., 2012; Figure 1). This process is facilitated by
the host proteins Serine/Threonine Kinase 11 (STK11), Myosin
X, Myosin II and Dia1 (Rathman et al., 2000; Heindl et al., 2010;
Bishai et al., 2013; Dragoi and Agaisse, 2014). Importantly, recent
work has demonstrated that T3SS secretion is suppressed during
intracellular replication but is reactivated during cell-cell spread
(Campbell-Valois et al., 2014). In agreement, using a system
that allows for the post-entry shutdown of T3SS activity, Kuehl
et al. demonstrated that cell to cell spread is dependent on T3SS
activity (Kuehl et al., 2014).
An important challenge Shigella must overcome during
intracellular replication is the avoidance of autophagy targeting
and degradation. Autophagy is a complex system for sequestering
cytoplasmic cargo in de novo generated double membrane
vesicles that subsequently fuse with lysosomes to allow
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for degradation of the cytoplasmic cargo. Although the
primary function of autophagy is the recycling of cytoplasmic
components or entire organelles, it can also be used as a
cellular defense pathway by targeting intracellular bacteria.
Ogawa et al. reported the first interaction of intracellular
Shigella with the autophagy machinery (Ogawa et al., 2005). In
this initial report, the authors demonstrated that the surface
protein IcsB was critical in reducing autophagy targeting and
that strains lacking IcsB are efficiently restricted by autophagy
(Ogawa et al., 2005). Interestingly, strains lacking IcsA (VirG)
and IcsB are not targeted by autophagy (Ogawa et al., 2005).
Subsequent work demonstrated that Tecpr1 is a host targeting
factor in this pathway (Ogawa et al., 2011). These findings
provided the first suggestion that the machinery involved in cell-
cell spread and intracellular motility is linked with autophagy
targeting.
A number of studies have suggested that Shigella is particularly
vulnerable to autophagy targeting when it is associated with
host cell membranes. Travassos et al. demonstrated that
the intracellular peptidoglycan pattern recognition receptors
(PRRs), NOD1 and NOD2, play a critical role in targeting
the autophagy machinery through interaction with autophagy
related 16 like 1 (ATG16L1) to the site of Shigella invasion
at the plasma membrane (Travassos et al., 2010). This
NOD-ATG16L1 interaction also regulates the proinflammatory
response triggered by Shigella invasion (Sorbara et al., 2013).
Furthermore, the host membrane remnants resulting from the
escape of Shigella from the entry vacuole can drive inflammatory
responses, and are also ubiquitinated and targeted for autophagic
degradation (Dupont et al., 2009). Mostowy et al. found that
intracellular Shigella can be trapped in Septin cages allowing for
autophagy targeting and removal. In contrast, bacteria with actin
tails are not Septin-caged or autophagy-targeted (Mostowy et al.,
2010).
Work from both Ogawa et al. and Mostowy et al. suggest
that components involved in actin based motility are necessary
for both autophagy targeting (IcsA), and escape (IcsB; Ogawa
et al., 2005; Mostowy et al., 2010). Recent work has shed light
on these findings. Campbell-Valois et al. demonstrated that the
cytosolic subset of Shigella during infection were not targeted to
the autophagy system, and that only bacteria already associated
with an entry vacuole or cell-cell spread event, as marked by
an active T3SS, were targeted (Campbell-Valois et al., 2015).
Furthermore, they found that IcsB and VirA are involved in
escape from the vacuole following cell-to-cell spread, and that
deficiency in either protein leads to increased LC3 targeting as
a result of an impaired escape process (Campbell-Valois et al.,
2015). In agreement, IcsA negative bacteria, deficient in cell-
to-cell spread, are also not targeted by Septins or autophagy
proteins (Ogawa et al., 2005, 2011; Mostowy et al., 2010).
Although the exact mechanism through which IcsB promotes
cell-to-cell spread is unknown, Kayath et al. demonstrated
that cholesterol binding by IcsB is necessary for its function
in autophagy avoidance (Kayath et al., 2010), suggesting that
cholesterol binding during cell-to-cell spread contributes to
escape. Together these findings are in agreement with a model in
which Shigella is efficiently targeted to autophagy in the context
of host membranes during either initial invasion or cell-to-cell
spread.
CONCLUSIONS
As is often the case with complex biological interactions between
infectious agents and the host, the discovery of mechanistic
insight and explanations uncovers additional questions. Some of
those, together with brief conclusions are presented below.
The in vivo relevance of the autophagy targeting mechanism
remains to be determined. In other words, does autophagy
actually restrict growth of Shigella in physiological conditions?
In addition to this, more work is needed to understand the
molecular mechanism of how Shigella is able to destabilize
membranes (either during initial invasion or cell-to-cell
spread) and how that relates to host recognition of cytosolic
Shigella.
While it is clear that infection with Shigella leads to the
upregulation of metabolic stress pathways, it is unclear how
the activation of these pathways contributes to host defense
against this pathogen. Similarly, it remains to be seen how the
upregulated stress pathway affects the transcriptional landscape
of Shigella-infected cells. It has previously been shown that
pyruvate is a major carbon source for intracellular Shigella,
however these studies have been performed using cancer cells
that extensively rely on glycolysis. To advance the understanding
further, it will be essential to determine if the same holds
true for primary intestinal epithelial cells, which represent a
physiological target of Shigella. Shigella infection induces mTOR
inhibition and eIF2alpha phosphorylation, but the extent to
which these pathways are regulated by specific Shigella effectors
remains poorly characterized. Identifying if, in addition to OspB,
Shigella has evolved means to manipulate these pathways will
be an important question for future investigations. Lastly, it
was proposed that Shigella may induce amino acid starvation in
host cells as a result of membrane damage, however, it currently
remains unclear how host membrane damage triggers amino acid
starvation.
Shigella effectors manipulate a variety of fundamental
processes in the host. The list of Shigella effectors is still growing,
along with the host processes that are targeted. The induction of
cell death remains one of the fundamental defense mechanisms
for host cells to combat infection. Further investigation into the
risk/benefit of pyroptosis for Shigella will help understand which
situations call for such a proinflammatory method of escape
from the host cell. Discovery of the noncanonical inflammasome
has raised interest concerning the exact nature of stimuli and
sensors used by the major inflammasomes, so research focused
on clarifying these pathways is needed. Finally, the identification
of the intercellular transfer of protective messengers like cGAMP
suggests that other paracrine messengers of infection may also
exist. This could represent an effective, proactive defense strategy
used by the host to counteract the deleterious consequence of the
injection of effectors during invasion by alerting non-infected,
neighboring cells.
Such progress in uncovering the pathogenesis of Shigella
infection suggests possibilities for the future of therapies and
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treatment for diseases of a bacterial nature. Perhaps the
most apparent treatment strategy would be designing specific
inhibitors of the T3SS effectors, to block the action of those
effectors that are critical to invasion and cell-to-cell spread.
Likewise, after understanding the metabolic changes Shigella
undergo during the infection process, limiting access to pyruvate
could halt propagation of the bacteria. However, with most
therapies that target specific components or processes of a
microbe, mutations and selection leading to resistance would
be a potential pitfall. With this in mind, an alternative route
therapies could take involve strengthening the host responses,
especially those that are targeted by the bacterial infection, before
the bacteria have a chance to target the cells. This defense happens
endogenously as surrounding cells amplify their defense when a
neighbor is infected, therefore should also work with exogenous
stimuli. Such avenues could include sustaining components of
the inflammatory and survival signaling pathways, or limiting
bacterial access to essential nutrients like iron in patients who
have been infected. Each direction will benefit from further
investigation into the molecular mechanisms behind Shigella
pathogenesis, and the breadth of host response to infection.
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